NEWARK, Del. — QPS Holdings, LLC said it has successfully implemented the Oracle Argus Safety database to enhance pharmacovigilance and safety case management across its clinical trial operations.
QPS, an award-winning contract research organization focused on bioanalysis and clinical trials, said adoption of the Oracle Argus drug safety platform reinforces its commitment to patient safety, regulatory compliance, and operational excellence for its global client base. The company said the system strengthens its ability to capture, manage, and report adverse events in line with regulatory requirements worldwide.
“Ensuring patient safety and data integrity is at the heart of what we do when conducting clinical trials,” said Derek Grimes, Executive Vice President and Global Head of Clinical Research at QPS Holdings, LLC. “Oracle Argus provides us with a robust, scalable solution to support the growing needs of our customer’s clinical trial portfolios and the evolving expectations of regulatory authorities worldwide.”
Oracle said the platform provides QPS with a globally recognized pharmacovigilance system designed to support compliance with stringent safety standards while improving operational efficiency.
“Oracle Argus provides QPS Holdings, LLC with a trusted, globally recognized drug safety platform that supports compliance with stringent pharmacovigilance standards and regulations, while streamlining end-to-end safety operations and insights at scale,” said Seema Verma, Executive Vice President and General Manager, Oracle Health and Life Sciences. “With our industry-leading solutions, QPS Holdings, LLC can further transform and elevate its safety case management for customers worldwide.”
QPS said the deployment of Oracle Argus will improve safety monitoring, enhance oversight and traceability across all phases of clinical trials, streamline pharmacovigilance workflows, and improve efficiency in regulatory reporting for global submissions.
As demand for new therapies continues to increase, QPS said contract research organizations play a critical role in balancing development speed with patient safety. The company said leveraging Oracle Argus supports its broader mission to accelerate pharmaceutical innovation by delivering customized research services to sponsors worldwide.
